144 related articles for article (PubMed ID: 17566558)
41. Proteomics researchers solidifying principles for data sharing.
Eastman Q
J Proteome Res; 2009 Jul; 8(7):3220. PubMed ID: 19575531
[No Abstract] [Full Text] [Related]
42. COMET and the challenge of drug safety screening.
Nicholson J; Keun H; Ebbels T
J Proteome Res; 2007 Nov; 6(11):4098-9. PubMed ID: 17892277
[No Abstract] [Full Text] [Related]
43. The clinical utility of genetic tests.
Munafò MR
Addiction; 2009 Jan; 104(1):127-8. PubMed ID: 19133897
[No Abstract] [Full Text] [Related]
44. Is proteomics the new genomics?
Cox J; Mann M
Cell; 2007 Aug; 130(3):395-8. PubMed ID: 17693247
[TBL] [Abstract][Full Text] [Related]
45. Proteomic technologies for prenatal diagnostics: advances and challenges ahead.
Choolani M; Narasimhan K; Kolla V; Hahn S
Expert Rev Proteomics; 2009 Feb; 6(1):87-101. PubMed ID: 19210129
[TBL] [Abstract][Full Text] [Related]
46. The future of biological mass spectrometry.
Vestal ML
J Am Soc Mass Spectrom; 2011 Jun; 22(6):953-9. PubMed ID: 21953036
[TBL] [Abstract][Full Text] [Related]
47. Industrial-scale proteomics analysis of human plasma.
Rose K
Methods Biochem Anal; 2005; 45():217-29. PubMed ID: 19235297
[No Abstract] [Full Text] [Related]
48. Microsatellites and genome scans-- a GAMES postscript.
Dyment DA; Ebers GC
J Neuroimmunol; 2007 Oct; 190(1-2):5-7. PubMed ID: 17765324
[No Abstract] [Full Text] [Related]
49. Proteomics in Caenorhabditis elegans.
Audhya A; Desai A
Brief Funct Genomic Proteomic; 2008 May; 7(3):205-10. PubMed ID: 18372286
[TBL] [Abstract][Full Text] [Related]
50. Five genetic variants associated with prostate cancer.
Gartner CE; Barendregt JJ; Hall WD
N Engl J Med; 2008 Jun; 358(25):2738-9; author reply 2741. PubMed ID: 18572445
[No Abstract] [Full Text] [Related]
51. Assessing genetic testing: who are the "lay experts"?
Goven J
Health Policy; 2008 Jan; 85(1):1-18. PubMed ID: 17645980
[TBL] [Abstract][Full Text] [Related]
52. Risky knowledges: the sociocultural impacts of personal genetics in a knowledge-driven economy.
Legge M; Fitzgerald R
N Z Med J; 2007 Sep; 120(1262):U2736. PubMed ID: 17891224
[TBL] [Abstract][Full Text] [Related]
53. Review of a current role of mass spectrometry for proteome research.
Chen CH
Anal Chim Acta; 2008 Aug; 624(1):16-36. PubMed ID: 18706308
[TBL] [Abstract][Full Text] [Related]
54. Implications of preclinical genetic diagnosis.
Hoar DI
Med Sect Proc; 1990; ():147-55. PubMed ID: 2103944
[No Abstract] [Full Text] [Related]
55. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
56. Breakthrough of the year. It's all about me.
Kaiser J
Science; 2007 Dec; 318(5858):1843. PubMed ID: 18096771
[TBL] [Abstract][Full Text] [Related]
57. Mass spectrometry-based proteomics in reproductive medicine.
Kolialexi A; Mavrou A; Spyrou G; Tsangaris GT
Mass Spectrom Rev; 2008; 27(6):624-34. PubMed ID: 18618655
[TBL] [Abstract][Full Text] [Related]
58. Analysis of mass spectrometry data in proteomics.
Matthiesen R; Jensen ON
Methods Mol Biol; 2008; 453():105-22. PubMed ID: 18712299
[TBL] [Abstract][Full Text] [Related]
59. Gene chips unmask cryptic diseases.
Check Hayden E
Nature; 2008 Sep; 455(7211):274-5. PubMed ID: 18800098
[No Abstract] [Full Text] [Related]
60. Perspectives for imaging mass spectrometry in the proteomics landscape.
MacAleese L; Stauber J; Heeren RM
Proteomics; 2009 Feb; 9(4):819-34. PubMed ID: 19212956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
